Search results
Meso Numismatics Updates Progress on Strategic Expansion Into the UAE With ReGen Dubai
NewMediaWire via Yahoo Finance· 7 days agoLAS VEGAS, NV - (NewMediaWire) - June 03, 2024 - Meso Numismatics, Inc. ("Meso Numismatics" or the...
Octane Medical acquires B. Braun’s global orthobiologics business
Digital Journal· 3 days agoOctane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global orthobiologics business from its long-term partner B. Braun. The acquisition ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 2 hours agoIndia Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad PR Newswire HYDERABAD, India, June 10, 2024 HYDERABAD, India, June 10, 2024 /PRNewswire/ -- The Bio Regenerative Precision Medicine Seminar, held from May 18-20, 2024
Longeveron enters contract manufacturing with Secretome deal By Investing.com
Investing.com· 7 days agoLongeveron Inc. (NASDAQ: LGVN), a biotech company specializing in regenerative medicine, has...
SANUWAVE Will Host a Conference Call on June 4, 2024 at 8:30 AM (ET) to Provide a Corporate Update
NewMediaWire via Yahoo Finance· 7 days agoEDEN PRAIRIE, MN - (NewMediaWire) - June 03, 2024 - SANUWAVE Health, Inc. (the "Company" or...
FibroBiologics Shares Up 38% on Withdrawn Equity Offering
Market Watch· 4 days agoFibroBiologics shares rose Thursday after the cell therapy and regenerative medicine company said it will no longer pursue a planned equity offering. The ...
Celularity reports advances in cancer T-cell therapy By Investing.com
Investing.com· 7 days agoCelularity Inc. (NASDAQ: CELU), a biotechnology firm specializing in regenerative medicine,...
Humacyte CEO Niklason buys $15k in company stock By Investing.com
Investing.com· 7 days agoNiklason purchased shares worth approximately $15,000. The transaction, dated June 3, 2024, involved...
CollPlant prints commercial-size regenerative breast implants By Investing.com
Investing.com· 2 days agoCollPlant Biotechnologies (NASDAQ:CLGN), an innovator in regenerative and aesthetic medicine, has...
Mesoblast (NASDAQ:MESO) Receives Overweight Rating from Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoCantor Fitzgerald reaffirmed their overweight rating on shares of Mesoblast (NASDAQ:MESO – Free Report) in a report released on Tuesday, Benzinga reports. Separately, StockNews.com downgraded ...